Business Advice

Pulmonary Delivery of Orally Inhaled Therapeutics

Format: Video | Document type: Business Advice | Promoted Content

This content is provided by Catalent Pharma Solutions, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Pulmonary Delivery of Orally Inhaled Therapeutics

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred contract development and manufacturing organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,500 partner programs and annually launches over 150 new products, and its flexible manufacturing platforms at 50+ global sites supply over 70 billion doses of nearly 8,000 products. Catalent is headquartered in Somerset, New Jersey.

More products. Better treatments. Reliably supplied.™

Supplier info centre